Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!

Analysis of TWEAK/TNFSF12 (Human) by MSD Hypersensitive Multi-Factor Electrochemiluminescence Analyzer (CAT#: STEM-MB-0616-LGZ)

Introduction

Tumor necrosis factor ligand superfamily member 12 (TNFSF12), also known as TNF-related weak inducer of apoptosis (TWEAK), is a protein that is encoded by the TNFSF12 gene in humans. The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This protein is a ligand for the FN14/TWEAKR receptor. This cytokine has overlapping signaling functions with TNF but displays a broader tissue distribution. Leukocytes are the main source of TWEAK, including human quiescent and activated monocytes, dendritic cells, and natural killer cells. TWEAK can induce apoptosis in a cell type-specific manner through multiple cell death pathways. This cytokine has also been found to promote the proliferation and migration of endothelial cells, thus acting as a regulator of angiogenesis.




Principle

MSD electrochemiluminescence technology is mainly based on ultra-sensitive multi-factor electrochemiluminescence analyzer MES0 Sector600 or Quickplex SQ120. Through dot matrix technology, the detection of 10 indicators per well can be realized in the 96-hole graphite electrode plate. It can also be customized to realize the screening detection of 100 index wells in a 24-well plate.

Applications

Immunology/Inflammation

Procedure

1. Coat the capture antibody on the well plate.
2. Add samples/calibrators.
3. Add detection antibody.
4. Read the plate and analyze the data.

Materials

• Sample Type: Plasma, Serum
Advertisement